Chronic migraine prophylaxis and CGRP therapy
Preventive migraine treatment · Neurology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Preventive management of frequent episodic or chronic migraine (15 or more headache days per month) using oral prophylactics, botulinum toxin and CGRP-targeted therapies. Goal is to reduce frequency, severity and acute medication use.
Red flags
- New or changing headache pattern
- Papilloedema or focal neurological signs
- Thunderclap component
- Pregnancy on topiramate or candesartan
- Worsening despite escalating acute medication (overuse)
Assessment
Differential diagnosis
- Medication-overuse headache
- Chronic tension-type headache
- New daily persistent headache
- Hemicrania continua
- Idiopathic intracranial hypertension
- Secondary headache (mass, venous thrombosis)
Investigations
- Detailed headache diary quantifying monthly headache and acute-medication days
- Assess for medication overuse
- Examination including fundoscopy and blood pressure
- Neuroimaging only if red flags or atypical features
- Baseline mood and comorbidity screen
- Pregnancy status before starting prophylaxis
Management
- Confirm chronic migraine (15+ headache days/month, 8+ migrainous, for over 3 months)
- Identify and treat coexisting medication-overuse headache first
- Address lifestyle, sleep, hydration and trigger management
- Start an oral preventive, choosing by comorbidity and tolerability
- Titrate slowly and trial each agent at adequate dose for 8-12 weeks before judging
- Offer botulinum toxin for chronic migraine failing oral agents
- Offer CGRP monoclonal antibody or gepant after failure of appropriate oral preventives
- Monitor response with headache diary and reduce acute medication reliance
- Review contraception and pregnancy plans for teratogenic agents
- Taper and stop effective preventives after sustained benefit where appropriate
Drugs & doses
Propranolol 80-160 mg PO daily (divided or modified-release)
Topiramate 25 mg PO nocte titrated to 50 mg BD
Amitriptyline 10-75 mg PO nocte
Candesartan 8-16 mg PO daily
OnabotulinumtoxinA 155-195 units IM over 31-39 sites every 12 weeks (chronic migraine)
Erenumab 70-140 mg SC monthly
Galcanezumab 240 mg SC loading then 120 mg SC monthly
Fremanezumab 225 mg SC monthly or 675 mg quarterly
Atogepant 60 mg PO daily; Rimegepant 75 mg PO every other day
Disposition
Outpatient neurology/headache clinic. Specialist referral for botulinum toxin and CGRP therapy where failure of standard preventives is documented.
Complications & pitfalls
- Medication-overuse headache
- Teratogenicity (topiramate, candesartan)
- Topiramate cognitive and renal stone effects
- Weight change and mood effects of preventives
- Constipation with CGRP antibodies
Exam pearls
- Treat medication overuse before judging preventive failure
- CGRP therapies work even after multiple oral failures; access often requires documented prior trials
- Topiramate reduces contraceptive efficacy and is teratogenic
- Allow 8-12 weeks at target dose before declaring a preventive ineffective
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.